3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Glioblastoma
1
Ependymoma
1
Central Nervous System Neoplasms
1
Interventions
Temozolomide
64
Radiotherapy
53
Filgrastim
28
Carboplatin
24
Etoposide
20
Irinotecan
17
Vincristine
16
Cyclophosphamide
16
Cisplatin
15
Carmustine
14
Peripheral Blood Stem Cell Transplantation
13
Magnetic Resonance Spectroscopy
12
Bevacizumab
12
Thiotepa
11
Thalidomide
11
Chemotherapy, Adjuvant
11
Methotrexate
10
Paclitaxel
9
Granulocyte Colony-Stimulating Factor
9
etoposide phosphate
8
Surgical Procedures, Operative
8
Procarbazine
8
Ifosfamide
8
sargramostim
7
Topotecan
7
O(6)-benzylguanine
7
Lomustine
7
Busulfan
7
Radiation
6
Melphalan
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Central Nervous System Neoplasms
×
ONC206
×
Clear all
NCT04732065
2026-03-17
PNOC023
University of California, San Francisco
Phase 1
Recruiting
208 enrolled